Loading, please wait....jpg)
.jpg)
The Premier March 20, 2024 CE webinar will be held from 12 - 1 pm EST. We are pleased to provide one (1) 60-minute knowledge-based, ACPE-accredited CE activity to pharmacists and pharmacy technicians.
WHAT LIES AHEAD - A LOOK AT THE BIOSIMILAR, INFECTIOUS DISEASES AND SPECIALTY/ONCOLOGY DRUG PIPELINE IN 2024-25
SPEAKER: Liya Davydov, PharmD, BCPS, BCGP, Senior Director, Clinical Pharmacy Services, Continuum of Care, Premier, Inc.
ACPE Universal Activity Number 0122-0000-24-008-L01-P/T [0.1 CEU] [1 Contact Hr.] (Live CE)
Date: Mar 20, 2024 12:00 PM - 01:00 PM
Fee
CE Hours
CE Units
Registration closes on Mar 20, 2024 12:10 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
|
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Support/Credits
Registration closes on Mar 20, 2024
at 12:10 PM
Registration Closed
Objectives
- Identify biosimilar agents that have been recently approved, rejected or currently under regulatory review
- List various reimbursement models/strategies for biosimilars
- Identify notable agents that have been recently approved, rejected, in late stages of development or under regulatory review for infectious diseases indications
- Identify specialty drugs currently under regulatory review for select indications
- List oral and parenteral oncology agents currently under regulatory review for various cancers
Speaker(s)/Author(s)
|
Liya Davydov, PharmD, BCPS, BCGP
|